Population immunity for influenza in population of Sverdlovsk Region in epidemic season of 2018–2019
https://doi.org/10.33667/2078-5631-2020-18-26-28
Abstract
Donor blood serum was tested to detect antibodies against circulating influenza viruses. The titer of specific antibodies was determined in the hemagglutination inhibition test (RTGA) against influenza viruses A/California/07/09(H1N1) pdm09, A/HongKong/4801/14(H3N2) and B/Brisben/46/15. In the pre-epidemic period 2018–2019, the immune layer of people with conditionally protective titers of antiviral antibodies was detected in terms of the lowest to A(H3N2) virus (50.0 %), the highest to influenza B (85.4 %). In the post-epidemic season of 2018–2019, the immune layer to influenza A(H1N1) pdm09 virus did not change significantly, which could indicate the preservation of the activity of this virus in the adult population; an increase in the immune layer of individuals with protective titers of antibodies to influenza A(H3N2) – 67.4 % and a decrease in influenza B virus – 49.2 %. A comparison of the results of laboratory data carried out in the pre- and post-epidemic seasons revealed significant differences in the number of people with average antibody titers against influenza A(H3N2) and B viruses (p < 0.05).
About the Authors
I. A. Malchikov
Yekaterinburg Research Institute of Viral Infections of the State Research Centre of Virology and Biotechnology ‘Vector’; Ural State Medical University
Russian Federation
Yekaterinburg
Russian Federation
Yekaterinburg
A. V. Slobodenyuk
Ural State Medical University
Russian Federation
Yekaterinburg
Russian Federation
Yekaterinburg
I. V. Vyalykh
Yekaterinburg Research Institute of Viral Infections of the State Research Centre of Virology and Biotechnology ‘Vector’
Russian Federation
Yekaterinburg
Russian Federation
Yekaterinburg
A. Yu. Markaran
Yekaterinburg Research Institute of Viral Infections of the State Research Centre of Virology and Biotechnology ‘Vector’
Russian Federation
Yekaterinburg
Russian Federation
Yekaterinburg
Yu. V. Grigorieva
Ural State Medical University
Russian Federation
Yekaterinburg
Russian Federation
Yekaterinburg
Yu. Yu. Burtseva
Yekaterinburg Research Institute of Viral Infections of the State Research Centre of Virology and Biotechnology ‘Vector’
Russian Federation
Yekaterinburg
Russian Federation
Yekaterinburg
I. P. Malchikova
Regional Blood Transfusion Station
Russian Federation
Yekaterinburg
Russian Federation
Yekaterinburg
References
1. Еропкин М. Ю., Даниленко Д. М., Коновало ва Н. И., Прокопец А. В. и др. Выделение и антигенная характеристика вирусов гриппа, циркулировавших в России в эпидемические сезоны 2009–2011 гг. В кн.: Грипп: эпидемиология, профилактика и лечение. Сборник статей. СПб.; 2011. С. 37–41.
2. Коншина О. С., Соминина А. А., Смородинцева Е. А., Столяров К. А., Никоноров И. Ю. Результаты многолетнего изучения популяционного иммунитета к вирусам гриппа А(H1N 1) pdm09, А(H3N 2) у взрослого населения России // Инфекция и иммунитет. 2017. Т. 7. № 1. С. 27–33.
3. Львов Д. К., Бурцева Е. И., Колобухина Л. В., Федякина И. Т. и др. Вирусологические, эпиде миологические, клинические, молекулярно-генетические особенности эпидемии гриппа 2015–2016 гг.: доминирование вируса гриппа А(H1N 1) pdm09 в России и странах Северного полушария. Вопросы вирусологии. 2016. 61. № 4. С. 159–166.
4. Методические указания «Методы определения показателей качества иммунобиологических препаратов для профилактики и диагностики гриппа» МУ 3.3.2.1758–03, утверждены 28 сентября 2003 г.
5. Методические указания «Профилактика ин фекционных болезней» МУ 3.1.2943–11, утверждены 15 июля 2011 г.
6. Brugh M. Jr. A simple method for recording and analyzing serological data // Avian Dis. 1978 Apr–Jun; 22 (2). Р. 362–365.
7. Delangue J., Salez N., Ninove L., Kieffer A., Zandotti C., Seston M., Lina B., Nougairede A., Charrel R., Flahault A., de Lamballerie X. Serological study of the 2009 pandemic due to influenza A H1N 1 in the metropolitan French population // Clin Microbiol Infect. 2012 Feb; 18 (2). P. 177–183.
8. Koopmans M., de Bruin E., Godeke G. J., Frie sema I., van Gageldonk R., Schipper M., Mei jer A., van Binnendijk R., Rimmelzwaan G. F., de Jong M. D., Buisman A, van Beek J, van de Vijver D, Reimerink. Profiling of humoral immune responses to influenza viruses by using protein microarray // J. Clin. Microbiol. Infect. 2012. Aug; 18 (8). P. 797–807.
9. Kumagai T., Nakayama T., Okuno Y., Kase T., et al. Humoral immune response to influenza A(H1N 1) pdm2009 in patients with natural infection and in vaccine recipients in the 2009 pandemic // Viral Immunol. 2014. Oct;27 (8). P. 368–374.
10. Korsun N., Angelova S., Gregory V., Daniels E., mGeorgieva I., McCauley J. Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/16 season // Infection, genetics and evolution. 2017 (49). P. 241–250.
11. World Health Organization surveillance network: manual for the laboratory diagnoses and virological surveillance of influenza. Geneva, WHO, 2011. P. 59–62.
Review
For citations:
Malchikov I.A., Slobodenyuk A.V., Vyalykh I.V., Markaran A.Yu., Grigorieva Yu.V., Burtseva Yu.Yu., Malchikova I.P. Population immunity for influenza in population of Sverdlovsk Region in epidemic season of 2018–2019. Medical alphabet. 2020;(18):26-28. (In Russ.) https://doi.org/10.33667/2078-5631-2020-18-26-28
Views:
346
Email this article 